Nature Knows and Psionic Success
God provides
ENCINITAS, Calif: Neurohacker Collective recently began a pilot study using the CBS Health platform powered by Cambridge Brain Sciences (CBS)-a leading provider of cognitive testing tools-to help customers receive quantitative feedback on their current brain health. In the initial pilot study, customers were self-selected and offered free cognitive testing with the purchase of Neurohacker Collective’s nootropic, Qualia Mind. Participants were asked to complete the testing three times: before starting on Qualia Mind, after their first dose of Qualia Mind, and the final test after five days of using Qualia Mind. The results for the 23 eligible subjects revealed meaningful improvement in core cognitive areas of reasoning, verbal ability and concentration. After 5 days of taking Qualia Mind, participants saw an average 85.4% increase in scores to measure ability to concentrate/avoid distraction, 37.2% increase in scores for planning skills, 31.1% increase in scores for visual representation, 16.9% increase in scores for verbal reasoning, 13.3% increase in scores for verbal short-term memory, and 10.2% increase in scores for episodic memory. While these are just preliminary findings on a small number of people, they are exciting initial results to see. For additional details on the study visit neurohacker.com/qualia-mind-pilot-study. Neurohacker Collective is now preparing to offer the program to all customers using Qualia Mind, who will have the option to take Cambridge Brain Sciences quantitative tests before and after starting to use the product so that each customer can see the changes in their cognitive function from an empirical standpoint. "I’m not surprised by the initial findings of the pilot study using CBS Health. They follow from a smaller study conducted last year measuring qEEG, stress profiles, other computerized assessment tools, and capnography where we saw objective improvement in brainwave patterns and cognitive performance from using Qualia," said Dr. Daniel Stickler, Medical Director […]
Click here to view full article
Pilot Study Indicates Qualia Mind Improving Reasoning, Episodic Memory, Verbal Ability and Concentration Neurohacker Collective Offering Free Cognitive Assessments with Purchases of Qualia Mind PR Newswire ENCINITAS, Calif., Aug. 7, 2018 ENCINITAS, Calif., Aug. 7, 2018 /PRNewswire/ — Neurohacker Collective recently began a pilot study using the CBS Health platform powered by Cambridge Brain Sciences (CBS)—a leading provider of cognitive testing tools—to help customers receive quantitative feedback on their current brain health. In the initial pilot study, customers were self-selected and offered free cognitive testing with the purchase of Neurohacker Collective’s nootropic, Qualia Mind . Participants were asked to complete the testing three times: before starting on Qualia Mind, after their first dose of Qualia Mind, and the final test after five days of using Qualia Mind. The results for the 23 eligible subjects revealed meaningful improvement in core cognitive areas of reasoning, verbal ability and concentration. After 5 days of taking Qualia Mind, participants saw an average 85.4% increase in scores to measure ability to concentrate/avoid distraction, 37.2% increase in scores for planning skills, 31.1% increase in scores for visual representation, 16.9% increase in scores for verbal reasoning, 13.3% increase in scores for verbal short-term memory, and 10.2% increase in scores for episodic memory. While these are just preliminary findings on a small number of people, they are exciting initial results to see. For additional details on the study visit neurohacker.com/qualia-mind-pilot-study . Neurohacker Collective is now preparing to offer the program to all customers using Qualia Mind, who will have the option to take Cambridge Brain Sciences quantitative tests before and after starting to use the product so that each customer can see the changes in their cognitive function from an empirical standpoint. "I’m not surprised by the initial findings of the pilot study using CBS Health. They […]
Click here to view full article
Leave a Reply
You must be logged in to post a comment.